2016中国国际药物信息大会暨第八届DIA中国年会.pdf

2016中国国际药物信息大会 暨第八届DIA 中国年会 th The 8 DIA China Annual Meeting 5月15–18日 | 北京国家会议中心 | 中国 May 15–18 | China National Convention Center, Beijing 迎接法规变革 聚力专业质量 Quality Transformation New Era of Drug Development Preliminary Program 2016 年 5 月 15 日 —— 会前专题研讨会 2016 年 5 月 16–18 日 —— 会议和展览 15 May, 2016 – Preconference Workshop 16–18 May, 2016 – Conference and Exhibition 4 DIA 欢迎致辞 WELCOME MESSAGES FROM DIA Message from DIA’s Global Chief Executive On behalf of DIA’s global network, welcome to the DIA China 2016 8th Annual Meeting: Quality Transformation – New Era of Drug Development. In 2016, China marks the first year of its 13th five-year planning cycle, and we are proud to be part of the remarkable progress and the promise of this new era. The State Council of China and the China Food Drug Administration (CFDA) have collaborated on a series of multifaceted regulatory reforms with significant goals, including improving the quality of drug review and approval, safeguarding the quality of generic drugs, enhancing regulatory transparency, and encouraging new drug research and development. Globally, these initiatives support the conduct of multiregional clinical trials, both in and outside of China, and using that data for product registration in China – creating a clinical, industry, and regu